These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 3124643)
1. Successful vaccination against murine Schistosoma mansoni infection with a purified 12 Kd Fasciola hepatica cross-reactive antigen. Hillyer GV; García Rosa MI; Alicea H; Hernandez A Am J Trop Med Hyg; 1988 Jan; 38(1):103-10. PubMed ID: 3124643 [TBL] [Abstract][Full Text] [Related]
2. Acquired immunity in schistosomiasis with purified Fasciola hepatica cross-reactive antigens. Hillyer GV; Soler de Galanes M; García Rosa MI; Montealegre F Vet Parasitol; 1988 Sep; 29(2-3):265-80. PubMed ID: 3144081 [TBL] [Abstract][Full Text] [Related]
3. The antigens of Paragonimus westermani, Schistosoma mansoni, and Fasciola hepatica adult worms. Evidence for the presence of cross-reactive antigens and for cross-protection to Schistosoma mansoni infection using antigens of Paragonimus westermani. Hillyer GV; Serrano AE Am J Trop Med Hyg; 1983 Mar; 32(2):350-8. PubMed ID: 6404188 [TBL] [Abstract][Full Text] [Related]
4. Induction of immunity in mice to Fasciola hepatica with a Fasciola/Schistosoma cross-reactive defined immunity antigen. Hillyer GV Am J Trop Med Hyg; 1985 Nov; 34(6):1127-31. PubMed ID: 3834796 [TBL] [Abstract][Full Text] [Related]
5. Isolation and partial characterization of an antigen shared between Schistosoma mansoni, Fasciola hepatica, and Biomphalaria glabrata. Rasmussen KR; Hillyer GV; Kemp WM J Parasitol; 1985 Dec; 71(6):792-8. PubMed ID: 2419536 [TBL] [Abstract][Full Text] [Related]
6. Fasciola hepatica and Schistosoma mansoni: immunofluorescent antigen localization and cross-reactivity. Hanna RE; Hillyer GV Exp Parasitol; 1984 Feb; 57(1):1-14. PubMed ID: 6198200 [TBL] [Abstract][Full Text] [Related]
7. Cross protection in infections due to Schistosoma mansoni using tegument antigens of Fasciola hepatica. Hillyer GV; Serrano AE J Infect Dis; 1982 May; 145(5):728-32. PubMed ID: 7077096 [TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of a major Schistosoma mansoni glycoprotein antigen cross-reactive with Fasciola hepatica. Aronstein WS; Dalton JP; Weiss JB; Strand M Am J Trop Med Hyg; 1985 Sep; 34(5):879-88. PubMed ID: 4037178 [TBL] [Abstract][Full Text] [Related]
9. Comparison of purified 12 kDa and recombinant 15 kDa Fasciola hepatica antigens related to a Schistosoma mansoni fatty acid binding protein. Hillyer GV Mem Inst Oswaldo Cruz; 1995; 90(2):249-53. PubMed ID: 8531666 [TBL] [Abstract][Full Text] [Related]
10. A Schistosoma mansoni surface glycoprotein cross-reactive with a T1 antigen of Fasciola hepatica. Aronstein WS; Dalton JP; Strand M Am J Trop Med Hyg; 1985 Sep; 34(5):889-97. PubMed ID: 4037179 [TBL] [Abstract][Full Text] [Related]
11. Fasciola hepatica: host responders and nonresponders to parasite glutathione S-transferase. Hillyer GV; Soler de Galanes M; Battisti G Exp Parasitol; 1992 Sep; 75(2):176-86. PubMed ID: 1516666 [TBL] [Abstract][Full Text] [Related]
12. Protection against Schistosoma mansoni infection using a Fasciola hepatica-derived fatty acid binding protein from different delivery systems. Vicente B; López-Abán J; Rojas-Caraballo J; del Olmo E; Fernández-Soto P; Muro A Parasit Vectors; 2016 Apr; 9():216. PubMed ID: 27090442 [TBL] [Abstract][Full Text] [Related]
13. A Schistosoma mansoni fatty acid-binding protein, Sm14, is the potential basis of a dual-purpose anti-helminth vaccine. Tendler M; Brito CA; Vilar MM; Serra-Freire N; Diogo CM; Almeida MS; Delbem AC; Da Silva JF; Savino W; Garratt RC; Katz N; Simpson AS Proc Natl Acad Sci U S A; 1996 Jan; 93(1):269-73. PubMed ID: 8552619 [TBL] [Abstract][Full Text] [Related]
14. Isolation and partial characterization of shared antigens of Biomphalaria glabrata and Schistosoma mansoni and their evaluation by the ELISA and the EITB. Rivera-Marrero CA; Hillyer GV J Parasitol; 1985 Oct; 71(5):547-55. PubMed ID: 3932633 [TBL] [Abstract][Full Text] [Related]
15. Vaccination against schistosomiasis and fascioliasis with the new recombinant antigen Sm14: potential basis of a multi-valent anti-helminth vaccine? Tendler M; Vilar MM; Brito CA; Freire NM; Katz N; Simpson A Mem Inst Oswaldo Cruz; 1995; 90(2):255-6. PubMed ID: 8531667 [TBL] [Abstract][Full Text] [Related]
16. Immunity of schistosomes using heterologous trematode antigens--a review. Hillyer GV Vet Parasitol; 1984 Jun; 14(3-4):263-83. PubMed ID: 6382782 [TBL] [Abstract][Full Text] [Related]
17. Mapping of B-cell epitopes on a novel 11.5-kilodalton Fasciola hepatica-Schistosoma mansoni cross-reactive antigen belonging to a member of the F. hepatica saposin-like protein family. Torres D; Espino AM Infect Immun; 2006 Aug; 74(8):4932-8. PubMed ID: 16861685 [TBL] [Abstract][Full Text] [Related]
18. Reevaluation of the potential of Fasciola hepatica antigens for immunization against Schistosoma mansoni infection. Ford MJ; Taylor MG; Bickle QD Parasitology; 1987 Apr; 94 ( Pt 2)():327-36. PubMed ID: 3108833 [TBL] [Abstract][Full Text] [Related]
19. Vaccination against Fasciola hepatica infection using a Schistosoma mansoni defined recombinant antigen, Sm14. Almeida MS; Torloni H; Lee-Ho P; Vilar MM; Thaumaturgo N; Simpson AJ; Tendler M Parasite Immunol; 2003 Mar; 25(3):135-7. PubMed ID: 12911521 [TBL] [Abstract][Full Text] [Related]
20. Isolation of potential serodiagnostic Fasciola hepatica antigens by electroelution from polyacrylamide gels. Santiago N; Hillyer GV Am J Trop Med Hyg; 1986 Nov; 35(6):1210-7. PubMed ID: 3538921 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]